CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls

First Page		Document Content
Date: 2015-01-29 07:33:53 Medicine Chemistry Brain Sodium valproate Valproic acid Lamotrigine Valproate semisodium Epilepsy Bipolar disorder Anticonvulsants Mood stabilizers Teratogens		CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 85,66 KB Share Document on Facebook

	Research Protocol for REAP Bipolar Disorder (REAP-BD) Summary REAP-BD survey will focus on the prescription patterns on bipolar disorder. Both inpatients and outpatients with bipolar disorder will be enrolled. Data in th DocID: 1uRe0 - View Document
	What you need to know about Bipolar Disorder What is it? Bipolar disorder is in a class of mood disorders that is marked by dramatic changes in mood, energy and DocID: 1u22A - View Document
	Patient information from BMJ Last published: Dec 01, 2016 Bipolar disorder: what is it? Most of us have ups and downs in our moods. But if you have bipolar disorder, your mood swings are much more extreme and disrupt you DocID: 1sX7O - View Document
	The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS DocID: 1sHB2 - View Document
	Health Net Behavioral Health Benefit Plan DocID: 1rmb0 - View Document